Buse Cevatemre

939 total citations
41 papers, 769 citations indexed

About

Buse Cevatemre is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Buse Cevatemre has authored 41 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 22 papers in Molecular Biology and 15 papers in Organic Chemistry. Recurrent topics in Buse Cevatemre's work include Metal complexes synthesis and properties (20 papers), Synthesis and biological activity (7 papers) and Cell death mechanisms and regulation (5 papers). Buse Cevatemre is often cited by papers focused on Metal complexes synthesis and properties (20 papers), Synthesis and biological activity (7 papers) and Cell death mechanisms and regulation (5 papers). Buse Cevatemre collaborates with scholars based in Türkiye, United States and United Kingdom. Buse Cevatemre's co-authors include Engı̇n Ulukaya, Veysel T. Yılmaz, Didem Karakaş, Ferda Arı, Ceyda Açılan, Ceyda İçsel, Nazlıhan Aztopal, Muhíttín Aygün, Zelal Adıgüzel and Mehmet Sarımahmut and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Journal of Cancer.

In The Last Decade

Buse Cevatemre

39 papers receiving 765 citations

Peers

Buse Cevatemre
Umasankar De South Korea
Merve Erkısa Türkiye
Zhenzhu Zhu China
Bing-Jie Han China
Fakhara Ahmed United States
Yunjun Liu China
Carla Ríos‐Luci Spain
Fung‐Ming Siu China
Shreelekha Adsule United States
Cinzia Aiello Italy
Umasankar De South Korea
Buse Cevatemre
Citations per year, relative to Buse Cevatemre Buse Cevatemre (= 1×) peers Umasankar De

Countries citing papers authored by Buse Cevatemre

Since Specialization
Citations

This map shows the geographic impact of Buse Cevatemre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buse Cevatemre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buse Cevatemre more than expected).

Fields of papers citing papers by Buse Cevatemre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buse Cevatemre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buse Cevatemre. The network helps show where Buse Cevatemre may publish in the future.

Co-authorship network of co-authors of Buse Cevatemre

This figure shows the co-authorship network connecting the top 25 collaborators of Buse Cevatemre. A scholar is included among the top collaborators of Buse Cevatemre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buse Cevatemre. Buse Cevatemre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cevatemre, Buse, et al.. (2025). Butyrylcholinesterase (BChE) downregulation in taxane resistance: implications for prostate cancer. TURKISH JOURNAL OF BIOLOGY. 49(3). 261–272.
2.
Cevatemre, Buse, et al.. (2024). Exploiting epigenetic targets to overcome taxane resistance in prostate cancer. Cell Death and Disease. 15(2). 132–132. 10 indexed citations
3.
4.
Cevatemre, Buse, et al.. (2022). Pyruvate Dehydrogenase Contributes to Drug Resistance of Lung Cancer Cells Through Epithelial Mesenchymal Transition. Frontiers in Cell and Developmental Biology. 9. 738916–738916. 9 indexed citations
5.
Erkısa, Merve, Şeyma Aydınlık, Buse Cevatemre, et al.. (2020). A promising therapeutic combination for metastatic prostate cancer: Chloroquine as autophagy inhibitor and palladium(II) barbiturate complex. Biochimie. 175. 159–172. 22 indexed citations
6.
Matos, Cristina P., Zelal Adıgüzel, Buse Cevatemre, et al.. (2019). May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?. European Journal of Medicinal Chemistry. 176. 492–512. 38 indexed citations
7.
İçsel, Ceyda, Veysel T. Yılmaz, Buse Cevatemre, Muhíttín Aygün, & Engı̇n Ulukaya. (2019). Structures and anticancer activity of chlorido platinum(II) saccharinate complexes with mono- and dialkylphenylphosphines. Journal of Inorganic Biochemistry. 195. 39–50. 25 indexed citations
8.
Matos, Cristina P., Zelal Adıgüzel, Buse Cevatemre, et al.. (2019). Experimental data on novel Fe(III)-complexes containing phenanthroline derivatives for their anticancer properties. SHILAP Revista de lepidopterología. 27. 104548–104548. 2 indexed citations
9.
10.
Kaçar, Ömer, Buse Cevatemre, Nazlı Arda, et al.. (2017). The role of cell cycle progression for the apoptosis of cancer cells induced by palladium(II)-saccharinate complexes of terpyridine. Bioorganic & Medicinal Chemistry. 25(6). 1770–1777. 24 indexed citations
11.
Açılan, Ceyda, Buse Cevatemre, Zelal Adıgüzel, et al.. (2016). Synthesis, biological characterization and evaluation of molecular mechanisms of novel copper complexes as anticancer agents. Biochimica et Biophysica Acta (BBA) - General Subjects. 1861(2). 218–234. 77 indexed citations
12.
Açılan, Ceyda, Buse Cevatemre, Zelal Adıgüzel, et al.. (2016). Validation data supporting the characterization of novel copper complexes as anticancer agents. Data in Brief. 9. 1160–1174. 4 indexed citations
13.
Cevatemre, Buse, et al.. (2016). The plant-derived triterpenoid tingenin B is a potent anticancer agent due to its cytotoxic activity on cancer stem cells of breast cancer in vitro. Chemico-Biological Interactions. 260. 248–255. 18 indexed citations
14.
Oral, Arzu Yılmaztepe, Buse Cevatemre, Mehmet Sarımahmut, et al.. (2015). Anti-growth effect of a novel trans-dichloridobis[2-(2-hydroxyethyl)pyridine]platinum (II) complex via induction of apoptosis on breast cancer cell lines. Bioorganic & Medicinal Chemistry. 23(15). 4303–4310. 15 indexed citations
15.
Cevatemre, Buse, Engı̇n Ulukaya, Mehmet Sarımahmut, Arzu Yılmaztepe Oral, & Fiona M. Frame. (2015). The M30 assay does not detect apoptosis in epithelial-derived cancer cells expressing low levels of cytokeratin 18. Tumor Biology. 36(9). 6857–6865. 9 indexed citations
16.
Arı, Ferda, Buse Cevatemre, Elif İlkay Armutak, et al.. (2014). Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo. Bioorganic & Medicinal Chemistry. 22(17). 4948–4954. 35 indexed citations
17.
Ulukaya, Engı̇n, Mehmet Sarımahmut, Buse Cevatemre, et al.. (2014). Additive enhancement of apoptosis by TRAIL and fenretinide in metastatic breast cancer cells in vitro. Biomedicine & Pharmacotherapy. 68(4). 477–482. 12 indexed citations
18.
Ulukaya, Engı̇n, Fiona M. Frame, Buse Cevatemre, et al.. (2013). Differential Cytotoxic Activity of a Novel Palladium-Based Compound on Prostate Cell Lines, Primary Prostate Epithelial Cells and Prostate Stem Cells. PLoS ONE. 8(5). e64278–e64278. 39 indexed citations
19.
Cevatemre, Buse, Ferda Arı, Mehmet Sarımahmut, et al.. (2013). Combination of fenretinide and indole-3-carbinol results in synergistic cytotoxic activity inducing apoptosis against human breast cancer cells in vitro. Anti-Cancer Drugs. 24(6). 577–586. 16 indexed citations
20.
Kaçar, Ömer, Zelal Adıgüzel, Veysel T. Yılmaz, et al.. (2013). Evaluation of the molecular mechanisms of a palladium(II) saccharinate complex with terpyridine as an anticancer agent. Anti-Cancer Drugs. 25(1). 17–29. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Umasankar De Breakdown of academic impact, for papers by Merve Erkısa Breakdown of academic impact, for papers by Zhenzhu Zhu Breakdown of academic impact, for papers by Bing-Jie Han Breakdown of academic impact, for papers by Fakhara Ahmed Breakdown of academic impact, for papers by Yunjun Liu Breakdown of academic impact, for papers by Carla Ríos‐Luci Breakdown of academic impact, for papers by Fung‐Ming Siu Breakdown of academic impact, for papers by Shreelekha Adsule Breakdown of academic impact, for papers by Cinzia Aiello
Rankless by CCL
2026